Greenleaf Trust’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,294
Closed -$260K 861
2024
Q3
$260K Buy
4,294
+416
+11% +$24.6K ﹤0.01% 713
2024
Q2
$218K Buy
+3,878
New +$216K ﹤0.01% 731
2023
Q2
Sell
-5,571
Closed -$366K 810
2023
Q1
$366K Buy
+5,571
New +$344K ﹤0.01% 538
2022
Q3
Sell
-3,270
Closed -$351K 750
2022
Q2
$351K Buy
3,270
+19
+0.6% +$1.94K 0.01% 502
2022
Q1
$361K Sell
3,251
-340
-9% -$35.5K ﹤0.01% 528
2021
Q4
$460K Buy
3,591
+60
+2% +$7.71K 0.01% 438
2021
Q3
$470K Buy
3,531
+458
+15% +$57.2K 0.01% 411
2021
Q2
$332K Buy
3,073
+44
+1% +$4.72K ﹤0.01% 535
2021
Q1
$319K Buy
3,029
+626
+26% +$69.8K ﹤0.01% 527
2020
Q4
$250K Buy
+2,403
New +$233K ﹤0.01% 522

Other funds holding CTLT

Greenleaf Trust's CTLT Position: Q4 2024 in Review

Greenleaf Trust sold out of CATALENT, INC. (CTLT) in Q4 2024, closing a stake of 4,294 shares — an estimated $260K sold.

Greenleaf Trust first reported a position in CTLT in Q4 2020 and held it in 10 quarters. The position peaked at $470K in Q3 2021. 6 funds tracked by Wall St. Rank hold CTLT as of Q4 2024.

  • Greenleaf Trust reported no remaining CATALENT, INC. position as of Q4 2024 after selling out during the quarter.
  • Greenleaf Trust sold 4,294 CATALENT, INC. shares in Q4 2024, an estimated $260K.
  • Greenleaf Trust first reported a position in CATALENT, INC. in Q4 2020 and held it in 10 quarters.
  • Greenleaf Trust's CATALENT, INC. position peaked at $470K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2024.

Based on Greenleaf Trust's 13F filing for Q4 2024, filed 24 Jan 2025.